ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 21, 2014 | $650,000 | Replaced |
| 4th Quarter - Amendment | Mar 26, 2014 | $650,000 | Replaced |
| 4th Quarter - Amendment | May 2, 2014 | $560,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Intellectual property and market access issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRADLEY ALLEN ROSSIN | — |
Taxation/Internal Revenue Code TAX
Reform of tax code and possible timing of any such reform bill (no bill number yet)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRADLEY ALLEN ROSSIN | — |
Copyright/Patent/Trademark CPT
H.R. 3309, S 1720, S 1013, S 1612 - patent litigation reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY | — |
| THERESA JOLIVETTE | — |
| BELA SASTRY | — |
Health Issues HCR
Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program H.R. 3204 and related legislative proposals - Drug safety and supply chain protections H.R. 3742 - Legislative proposals regarding the development of antibiotics H.R. 2725, S. 1413 - FDA user feesFederal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration General discussions regarding patient adherence to prescribed medications regimens
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY | — |
| THERESA JOLIVETTE | — |
| JACQUELINE POMFRET KIRBY | — |
| BELA SASTRY | — |
| ANDREA WILKINSON New | SenBreaux, MerchMar&FishComm, CongMcCrery |
Medicare/Medicaid MMM
H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs H.R. 1588, S. 740 - issues related to pharmaceutical rebates in Medicare Part D
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA JOLIVETTE | — |
| JACQUELINE POMFRET KIRBY | — |
| BELA SASTRY | — |
| ANDREA WILKINSON New | SenBreaux, MerchMar&FishComm, CongMcCrery |
Consumer Issues/Safety/Products CSP
H.R. 3204 and related legislative proposals - Drug safety and supply chain protections
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY | — |
| THERESA JOLIVETTE | — |
| BELA SASTRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.